Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has informed the stock exchanges that its trading window will remain closed from October 1, 2025 until 48 hours after the company declares its financial results for the quarter ending September 30, 2025. This is a standard compliance action under SEBI's Insider Trading Regulations, 2015, and the notice has been circulated to all designated and connected persons of the company. The date of the board meeting where the Q2 FY26 results will be approved has not yet been announced and will be communicated separately. This is a routine regulatory disclosure with no operational or financial impact disclosed.
No direct impact on shareholders or stock price. This is a routine insider trading compliance notice that typically signals upcoming quarterly earnings, as insiders are barred from trading during this period.